These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7865106)

  • 21. Increased interleukin-10 production without expansion of CD4+CD25+ T-regulatory cells in early stable renal transplant patients on calcineurin inhibitors.
    Mittal SK; Sharma RK; Gupta A; Naik S
    Transplantation; 2009 Aug; 88(3):435-41. PubMed ID: 19667950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An investigation to assess the potential of CD25highCD4+ T cells to regulate responses to donor alloantigens in clinically stable renal transplant recipients.
    Akl A; Jones ND; Rogers N; Bakr MA; Mostafa A; El Shehawy el M; Ghoneim MA; Wood KJ
    Transpl Int; 2008 Jan; 21(1):65-73. PubMed ID: 17887959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kidney transplantation after liver transplantation from the same donor: four cases of successful steroid withdrawal.
    Fuchinoue S; Sawada T; Tsuji K; Kai K; Tojimbara T; Nakajima I; Shiraga H; Ito K; Teraoka S
    Transplantation; 2002 Mar; 73(6):948-52. PubMed ID: 11923698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal transplant patients treated with total lymphoid irradiation show specific unresponsiveness to donor antigens the mixed leukocyte reaction (MLR).
    Chow D; Saper V; Strober S
    J Immunol; 1987 Jun; 138(11):3746-50. PubMed ID: 2953791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of renal transplant histology at three months.
    Kuypers DR; Chapman JR; O'Connell PJ; Allen RD; Nankivell BJ
    Transplantation; 1999 May; 67(9):1222-30. PubMed ID: 10342313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The presence of B-cell nodules does not necessarily portend a less favorable outcome to therapy in patients with acute cellular rejection of a renal allograft.
    Doria C; di Francesco F; Ramirez CB; Frank A; Iaria M; Francos G; Marino IR; Farber JL
    Transplant Proc; 2006 Dec; 38(10):3441-4. PubMed ID: 17175297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro donor-specific hyporesponsiveness and T cell subsets in renal allograft recipients.
    Bas J; Mestre M; Griñó JM; Massip E; Castelao AM; Romeu A; González L; Valls A; Buendía E
    Allergol Immunopathol (Madr); 1993; 21(4):136-40. PubMed ID: 8237717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
    Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP
    Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The failure of skin grafting to break tolerance to class I-disparate renal allografts in miniature swine despite inducing marked antidonor cellular immunity.
    Rosengard BR; Kortz EO; Ojikutu CA; Guzzetta PC; Sundt TM; Smith CV; Nakajima K; Boorstein SM; Hill GS; Sachs DH
    Transplantation; 1991 Dec; 52(6):1044-52. PubMed ID: 1750067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection.
    Khosroshahi HT; Tubbs RS; Shoja MM; Ghafari A; Noshad H; Ardalan MR
    Transplant Proc; 2008; 40(1):137-9. PubMed ID: 18261569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A study of endothelial cell-lymphocyte responses in human renal transplantation.
    Abdulkarim AB; Barnes AD; Adu D; Catty D
    Clin Transplant; 1999 Feb; 13(1 Pt 2):113-22. PubMed ID: 10081647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimization of immunosuppressive therapy based on a multiparametric mixed lymphocyte reaction assay reduces infectious complications and mortality in living donor liver transplant recipients.
    Tanaka Y; Tashiro H; Onoe T; Ide K; Ishiyama K; Ohdan H
    Transplant Proc; 2012 Mar; 44(2):555-9. PubMed ID: 22410068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C4D deposition and positive posttransplant crossmatch are not necessarily markers of antibody-mediated rejection in renal allograft recipients.
    Banasik M; Boratyńska M; Nowakowska B; Haloń A; Kościelska-Kasprzak K; Drulis-Fajdasz D; Patrzałek D; Weyde W; Klinger M
    Transplant Proc; 2007 Nov; 39(9):2718-20. PubMed ID: 18021967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Banff borderline acute rejection among renal allograft recipients.
    Matoza JR; Danguilan RA; Chicano S
    Transplant Proc; 2008 Sep; 40(7):2303-6. PubMed ID: 18790219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rebound effect of the allogenic T-cell response to donor and third-party lymphocytes after cyclosporine withdrawal in renal transplant recipients.
    Creemers P; Pascoe MD; Pontin AR; Kahn D
    Transpl Immunol; 1998 Dec; 6(4):261-4. PubMed ID: 10342740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of early acute rejection with daclizumab and triple immunosuppression in cadaveric renal allograft recipients.
    Kandus A; Grego K; Bren AF
    Ther Apher Dial; 2005 Jun; 9(3):262-4. PubMed ID: 15967003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of donor-specific unresponsiveness to rat cardiac allografts by intrathymic injection of UV-B-irradiated donor spleen cells.
    Oluwole SF; Chowdhury NC; Fawwaz RA
    Transplantation; 1993 Jun; 55(6):1389-95. PubMed ID: 8516824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequential mixed lymphocyte culture after kidney transplantation: induction of tolerance or sensitization.
    Creemers P; Du Toit E; Cassidy MJ; Kahn D
    Nephron; 1997; 75(2):166-70. PubMed ID: 9041536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Donor-specific cellular immunity in rejecting and long-term-surviving class I-disparate rat renal allograft recipients.
    Ruiz P; Fuller J; Sanfilippo F
    Transplantation; 1990 Jan; 49(1):175-83. PubMed ID: 2301009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-HLA antibodies and kidney allograft outcomes in recipients with donor bone marrow cell infusion.
    Solgi G; Pourmand G; Mehrsai A; Taherimahmoudi M; Nicknam MH; Ebrahimi Rad MR; Seraji A; Asadpoor A; Ansaripor B; Nikbin B; Amirzargar A
    Iran J Immunol; 2010 Mar; 7(1):18-29. PubMed ID: 20371916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.